Clinical Trial Update: Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of apatinib for advanced hepatocellular carcinoma; the update does not provide results and lists the status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN